VORINOSTAT INDUCES ARID1A SPLICING VARIANT EXPRESSION WHICH MAY REGULATE HNF1B AND CELL SURVIVAL, IN OVARIAN CLEAR CELL CARCINOMA (CCC)

被引：0
|
作者：
Silva, F. [1 ]
Fernandes, S. [1 ]
Felix, A. [2 ]
Serpa, J. [1 ]
机构：
[1] UIPM IPOLFG, CEDOC FCM UNL, Lisbon, Portugal
[2] UIPM IPOLFG, CEDOC FCM UNL, Pathol Dept IPOLFG, Lisbon, Portugal
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component
    Nishikimi, Kyoko
    Kiyokawa, Takako
    Tate, Shinichi
    Iwamoto, Masami
    Shozu, Makio
    HISTOPATHOLOGY, 2015, 67 (06) : 866 - 871
  • [2] Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
    Choi, Jae Yoon
    Han, Hyun Ho
    Kim, Young Tae
    Lee, Joo Hyun
    Kim, Baek Gil
    Kang, Suki
    Cho, Nam Hoon
    YONSEI MEDICAL JOURNAL, 2017, 58 (01) : 59 - 66
  • [3] Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
    Yamaguchi, Ken
    Kitamura, Sachiko
    Furutake, Yoko
    Murakami, Ryusuke
    Yamanoi, Koji
    Taki, Mana
    Ukita, Masayo
    Hamanishi, Junzo
    Mandai, Masaki
    CANCERS, 2021, 13 (10)
  • [4] Biomolecular features of ARID1A, HNF1β and ERα in clear cell carcinoma of the ovary
    Abou-Taleb, H.
    Yamaguchi, K.
    Mandai, M.
    Amano, Y.
    Kosaka, K.
    Matsumura, N.
    Baba, T.
    Yoshioka, Y.
    Hamanishi, J.
    Konishi, I
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 159 - 160
  • [5] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    MODERN PATHOLOGY, 2011, 24 : 259A - 259A
  • [6] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    Xiao, Wenbin
    Awadallah, Amad
    Xin, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (07): : 642 - 650
  • [7] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
    Katagiri, Atsuko
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Rahman, Munmun
    Katagiri, Hiroshi
    Nakayama, Naomi
    Ishikawa, Masako
    Ishibashi, Tomoka
    Iida, Kouji
    Kobayashi, Hiroshi
    Otsuki, Yoshiro
    Nakayama, Satoru
    Miyazaki, Kohji
    MODERN PATHOLOGY, 2012, 25 (02) : 282 - 288
  • [8] Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
    Maeda, Daichi
    Mao, Tsui-Lien
    Fukayama, Masashi
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Shih, Ie-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2010, 11 (12): : 5121 - 5129
  • [9] Clinicopathological Significance of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma.
    Maeda, D.
    Mao, T-L
    Fukayama, M.
    Wang, T-L
    Shih, I-M
    LABORATORY INVESTIGATION, 2011, 91 : 259A - 259A
  • [10] The role of chromatin remodeler protein ARID1a in ovarian clear cell carcinoma
    Lakshminarasimhan, Ranjani
    Andreu-Vieyra, Claudia
    Lawrenson, Kate
    Gayther, Simon A.
    Jones, Peter A.
    Liang, Gangning
    CANCER RESEARCH, 2016, 76
12345